| 000 | 01014nam a2200289 a 4500 | ||
|---|---|---|---|
| 005 | 20250918151255.0 | ||
| 008 | 120309s2011 nyu 000 0 eng d | ||
| 020 |
_a9780199734313 _cRM32.02 |
||
| 039 | 9 |
_a201203261104 _bzainol _c201203091144 _dyusri _y03-09-2012 _zyusri |
|
| 040 | _aUKM | ||
| 090 | _aWK810.D654m 2011 9 | ||
| 090 |
_aWK810 _b.D654m 2011 9 |
||
| 100 | 1 | _aDagogo-Jack, Samuel | |
| 245 | 1 | 0 |
_aMedications and diabetes risk : _bmechanisms and approach to risk reduction / _cSamuel Dagogo-Jack |
| 260 |
_aMadison Avenue : _bOxford University Press, Inc, _c2011 |
||
| 300 |
_a95 p. ; _c17 cm. |
||
| 650 | 2 |
_aDrugs _xSide effects |
|
| 650 | 2 | _aDrug interactions | |
| 650 | 2 | _aHyproglycemic agents | |
| 650 | 2 |
_aDiabetes _xtreatment & complications |
|
| 907 |
_a.b15264890 _b2021-05-28 _c2019-11-12 |
||
| 942 |
_c01 _n0 _kWK810.D654m 2011 9 |
||
| 914 | _avtls003490141 | ||
| 991 | _aProgram Sains Bioperubatan, KKL | ||
| 998 |
_ad _b2012-09-03 _cm _da _feng _gnyu _y0 _z.b15264890 |
||
| 999 |
_c510551 _d510551 |
||